JANET GRIPSHOVER: Open Payments
NPI 1851431290 · WEST HOLLYWOOD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$7,257 in 22 payments from 4 companies in 2025. Trend: 2023 $107 · 2024 $227 · 2025 $7,257
Consulting: $5,720Food & beverage: $1,537
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 13 | $5,353 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $1,577 |
| Gilead Sciences, Inc. | 2 | $255 |
| GENZYME CORPORATION | 1 | $72 |
Products named: TRULANCE, REZDIFFRA, XIFAXAN, DUPIXENT.
Industry payments across CA — which companies pay providers there.
